Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer

Biochemistry

Volumn 43, Issue 27, 2004, Pages 8754-8765

  Mueller, Benjamin ^a   Karim, Christine B ^a   Negrashov, Igor V ^a   Kutchai, Howard ^b   Thomas, David D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BIOLOGICAL MEMBRANES; DISSOCIATION; ENERGY TRANSFER; ENZYME KINETICS; FLUORESCENCE; PHYSIOLOGY; STOICHIOMETRY;

FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET); INHIBITORY COMPLEX; SARCOPLASMIC RETICULUM;

BIOCHEMISTRY;

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); PHOSPHOLAMBAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SYNTHETIC PEPTIDE;

ANIMAL TISSUE; ARTICLE; ENERGY TRANSFER; ENZYME ACTIVITY; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RABBIT; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; STOICHIOMETRY;

CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CELL MEMBRANE; FLUORESCENCE RESONANCE ENERGY TRANSFER; ISOLEUCINE; MUTATION; PROTEIN BINDING; SARCOPLASMIC RETICULUM;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 3042730955     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049732k     Document Type: Article

References (68)

1. Tada, M., Kadoma, M., Fujii, J., Kimura, Y., and Kijima, Y. (1989) Molecular structure and function of phospholamban: the regulatory protein of calcium pump in cardiac sarcoplasmic reticulum, Adv. Exp. Med. Biol. 255, 79-89.
2. 2+ uptake in mammalian ventricular myocytes, Am. J. Physiol. 261, H1344-9.
3. Dhalla, N. S., Panagia, V., Singal, P. K., Makino, N., Dixon, I. M., and Eyolfson, D. A. (1988) Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury, J. Mol. Cell. Cardiol. 20 (Suppl. 2), 3-13.
4. Minamisawa, S., Hoshijima, M., Chu, G., Ward, C. A., Frank, K., Gu, Y., Martone, M. E., Wang, Y., Ross, J., Jr., Kranias, E. G., Giles, W. R., and Chien, K. R. (1999) Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell 99, 313-22.
5. Minamisawa, S., Sato, Y., Tatsuguchi, Y., Fujino, T., Imamura, S., Uetsuka, Y., Nakazawa, M., and Matsuoka, R. (2003) Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy, Biochem. Biophys. Res. Commun. 304, 1-4.
6. 2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy, Circ. Res. 65, 1141-4.
7. Sande, J. B., Sjaastad, I., Hoen, I. B., Bokenes, J., Tonnessen, T., Holt, E., Lunde, P. K., and Christensen, G. (2002) Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity, Cardiovasc. Res. 53, 382-91.
8. Haghighi, K., Kolokathis, F., Pater, L., Lynch, R. A., Asahi, M., Gramolini, A. O., Fan, G. C., Tsiapras, D., Hahn, H. S., Adamopoulos, S., Liggett, S. B., Dorn, G. W., II, MacLennan, D. H., Kremastinos, D. T., and Kranias, E. G. (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest. 111, 869-76.
9. 2+ uptake in sarcoplasmic reticulum from normal and failing hearts, J. Clin. Invest. 85, 1698-702.
10. Schmitt, J. P., Kamisago, M., Asahi, M., Li, G. H., Ahmad, F., Mende, U., Kranias, E. G., MacLennan, D. H., Seidman, J. G., and Seidman, C. E. (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science 299, 1410-3.
11. Zhao, W., Frank, K. F., Chu, G., Gerst, M. J., Schmidt, A. G., Ji, Y., Periasamy, M., and Kranias, E. G. (2003) Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state, Cardiovasc. Res. 57, 71-81.
12. Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., and Kranias, E. G. (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ. Res. 75, 401-9.
13. Lorenz, J. N., and Kranias, E. G. (1997) Regulatory effects of phospholamban on cardiac function in intact mice, Am. J. Physiol. 273, H2826-31.
14. Schmidt, A. G., Edes, I., and Kranias, E. G. (2001) Phospholamban: a promising therapeutic target in heart failure?, Cardiovasc. Drugs Ther. 15, 387-96.
15. Hoshijima, M., Ikeda, Y., Iwanaga, Y., Minamisawa, S., Date, M. O., Gu, Y., Iwatate, M., Li, M., Wang, L., Wilson, J. M., Wang, Y., Ross, J., Jr., and Chien, K. R. (2002) Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat. Med. 8, 864-71.
16. Cornea, R. L., Jones, L. R., Autry, J. M., and Thomas, D. D. (1997) Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry 36, 2960-7.
17. Kimura, Y., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1997) Phospholamban inhibitory function is activated by depolymerization, J. Biol. Chem. 272, 15061-4.
18. Thomas, D. D., Reddy, L. G., Karim, C. B., Li, M., Cornea, R., Autry, J. M., Jones, L. R., and Stamm, J. (1998) Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban, Ann. N. Y. Acad. Sci. 853, 186-94.
19. MacLennan, D. H., and Kranias, E. G. (2003) Phospholamban: a crucial regulator of cardiac contractility, Nat. Rev. Mol. Cell. Biol. 4, 566-77.
20. MacLennan, D. H., Kimura, Y., and Toyofuku, T. (1998) Sites of regulatory interaction between calcium ATPases and phospholamban, Ann. N. Y. Acad. Sci. 853, 31-42.
21. 2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP, J. Biol. Chem. 275, 15034-8.
22. 2+ pump of sarcoplasmic reticulum, Nature 342, 90-2.
23. 2+ pump revealed with use of heterobifunctional cross-linking agents, J. Biol. Chem. 278, 48348-56.
24. 2+ pump revealed by intermolecular thiol cross-linking, J. Biol. Chem. 277, 28319-29.
25. Young, E. F., McKee, M. J., Ferguson, D. G., and Kranias, E. G. (1989) Structural characterization of phospholamban in cardiac sarcoplasmic reticulum membranes by cross-linking, Membr. Biochem. 8, 95-106.
26. Tatulian, S. A., Chen, B., Li, J., Negash, S., Middaugh, C. R., Bigelow, D. J., and Squier, T. C. (2002) The inhibitory action of phospholamban involves stabilization of alpha-helices within the Ca-ATPase, Biochemistry 41, 741-51.
27. Mersol, J. V., Kutchai, H., Mahaney, J. E., and Thomas, D. D. (1995) Self-association accompanies inhibition of Ca-ATPase by thapsigargin, Biophys. J. 68, 208-15.
28. Karon, B. S., Geddis, L. M., Kutchai, H., and Thomas, D. D. (1995) Anesthetics alter the physical and functional properties of the Ca-ATPase in cardiac sarcoplasmic reticulum, Biophys. J. 68, 936-45.
29. Kutchai, H., Geddis, L. M., Jones, L. R., and Thomas, D. D. (1998) Differential effects of general anesthetics on the quaternary structure of the Ca-ATPases of cardiac and skeletal sarcoplasmic reticulum, Biochemistry 37, 2410-21.
30. Voss, J., Jones, L. R., and Thomas, D. D. (1994) The physical mechanism of calcium pump regulation in the heart, Biophys. J. 67, 190-6.
31. Karim, C. B., Marquardt, C. G., Stamm, J. D., Barany, G., and Thomas, D. D. (2000) Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry 39, 10892-7.
32. Karim, C. B., Paterlini, M. G., Reddy, L. G., Hunter, G. W., Barany, G., and Thomas, D. D. (2001) Role of cysteine residues in structural stability and function of a transmembrane helix bundle, J. Biol. Chem. 276, 38814-9.
33. Lockwood, N. A., Tu, R. S., Zhang, Z., Tirrell, M. V., Thomas, D. D., and Karim, C. B. (2003) Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban, Biopolymers 69, 283-92.
34. Tarr, G. E., Black, S. D., Fujita, V. S., and Coon, M. J. (1983) Complete amino acid sequence and predicted membrane topology of phenobarbital-induced cytochrome P-450 (isozyme 2) from rabbit liver microsomes, Proc. Natl. Acad. Sci. U.S.A. 80, 6552-6.
35. King, D. S., Fields, C. G., and Fields, G. B. (1990) A cleavage method which minimizes side reactions following Fmoc solid-phase peptide synthesis, Int. J. Pept. Protein Res. 36, 255-66.
36. Arkin, I. T., Adams, P. D., Brunger, A. T., Aimoto, S., Engelman, D. M., and Smith, S. O. (1997) Structure of the transmembrane cysteine residues in phospholamban, J. Membr. Biol. 155, 199-206.
37. Stokes, D. L., and Green, N. M. (1990) Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J. 57, 1-14.
38. Lowry, H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurements with the Folin phenol reagent, J. Biol. Chem. 193, 265-275.
39. Birmachu, W., Nisswandt, F. L., and Thomas, D. D. (1989) Conformational transitions in the calcium adenosinetriphosphatase studied by time-resolved fluorescence resonance energy transfer, Biochemistry 28, 3940-7.
40. Reddy, L. G., Autry, J. M., Jones, L. R., and Thomas, D. D. (1999) Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure, J. Biol. Chem. 274, 7649-55.
41. Reddy, L. G., Jones, L. R., Cala, S. E., O'Brian, J. J., Tatulian, S. A., and Stokes, D. L. (1995) Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca(2+)-ATPase, J. Biol. Chem. 270, 9390-7.
42. 2+/ calmodulin-dependent protein kinase, J. Biol. Chem. 271, 14964-70.
43. Reddy, L. G., Cornea, R. L., Winters, D. L., McKenna, E., and Thomas, D. D. (2003) Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry 42, 4585-92.
44. Fabiato, A., and Fabiato, F. (1979) Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells, J. Physiol. (Paris) 75, 463-505.
45. Li, M., Reddy, L. G., Bennett, R., Silva, N. D., Jr., Jones, L. R., and Thomas, D. D. (1999) A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban, Biophys. J. 76, 2587-99.
46. Young, H. S., Jones, L. R., and Stokes, D. L. (2001) Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy, Biophys. J. 81, 884-94.
47. Hutter, M. C., Krebs, J., Meiler, J., Griesinger, C., Carafoli, E., and Helms, V. (2002) A structural model of the complex formed by phospholamban and the calcium pump of sarcoplasmic reticulum obtained by molecular mechanics, Chembiochem 3, 1200-8.
48. 2+ ATPase, Proc. Natl. Acad. Sci. U.S.A. 100, 467-72.
49. Fung, B. K., and Stryer, L. (1978) Surface density determination in membranes by fluorescence energy transfer, Biochemistry 17, 5241-8.
50. Dewey, T. G., and Hammes, G. G. (1980) Calculation on fluorescence resonance energy transfer on surfaces, Biophys. J. 32, 1023-35.
51. Birmachu, W., and Thomas, D. D. (1990) Rotational dynamics of the Ca-ATPase in sarcoplasmic reticulum studied by time-resolved phosphorescence anisotropy, Biochemistry 29, 3904-14.
52. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680-5.
53. Young, H. S., Rigaud, J. L., Lacapere, J. J., Reddy, L. G., and Stokes, D. L. (1997) How to make tubular crystals by reconstitution of detergent-solubilized Ca2(+)-ATPase, Biophys. J. 72, 2545-58.
54. Toyoshima, C., and Nomura, H. (2002) Structural changes in the calcium pump accompanying the dissociation of calcium, Nature 418, 605-11.
55. Toyoshima, C., Nakasako, M., Nomura, H., and Ogawa, H. (2000) Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution, Nature 405, 647-55.
56. Ferrington, D. A., Yao, Q., Squier, T. C., and Bigelow, D. J. (2002) Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum, Biochemistry 41, 13289-96.
57. Briggs, F. N., Lee, K. F., Wechsler, A. W., and Jones, L. R. (1992) Phospholamban expressed in slow-twitch and chronically stimulated fast-twitch muscles minimally affects calcium affinity of sarcoplasmic reticulum Ca(2+)-ATPase, J. Biol. Chem. 267, 26056-61.
58. Colyer, J., and Wang, J. H. (1991) Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban, J. Biol. Chem. 266, 17486-93.
59. Negash, S., Chen, L. T., Bigelow, D. J., and Squier, T. C. (1996) Phosphorylation of phospholamban by cAMP-dependent protein kinase enhances interactions between Ca-ATPase polypeptide chains in cardiac sarcoplasmic reticulum membranes, Biochemistry 35, 11247-59.
60. Reddy, L. G., Jones, L. R., and Thomas, D. D. (1999) Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study, Biochemistry 38, 3954-62.
61. Mahaney, J. E., Froechlich, J. P., and Thomas, D. D. (1995) Conformational transitions of the sarcoplasmic reticulum Ca-ATPase studied by time-resolved EPR and quenched-flow kinetics, Biochemistry 34, 4864-79.
62. Kirby, T. L., Karim, C. B., and Thomas, D. D. (2004) EPR reveals a large-scale conformational change in the cytoplasmic domain of PLB upon binding to the SR Ca-ATPase, Biochemistry 42, 5842-52.
63. Karon, B. S., Autry, J. M., Shi, Y., Garnett, C. E., Inesi, G., Jones, L. R., Kutchai, H., and Thomas, D. D. (1999) Different anesthetic sensitivities of skeletal and cardiac isoforms of the Ca-ATPase, Biochemistry 38, 9301-7.
64. Xu, C., Rice, W. J., He, W., and Stokes, D. L. (2002) A structural model for the catalytic cycle of Ca(2+)-ATPase, J. Mol. Biol. 316, 201-11.
65. Birmachu, W., Voss, J. C., Louis, C. F., and Thomas, D. D. (1993) Protein and lipid rotational dynamics in cardiac and skeletal sarcoplasmic reticulum detected by EPR and phosphorescence anisotropy, Biochemistry 32, 9445-53.
66. Kutchai, H., Mahaney, J. E., Geddis, L. M., and Thomas, D. D. (1994) Hexanol and lidocaine affect the oligomeric state of the Ca-ATPase of sarcoplasmic reticulum, Biochemistry 33, 13208-22.
67. Voss, J. C., Mahaney, J. E., and Thomas, D. D. (1995) Mechanism of Ca-ATPase inhibition by melittin in skeletal sarcoplasmic reticulum, Biochemistry 34, 930-9.
68. Karon, B. S., Mahaney, J. E., and Thomas, D. D. (1994) Halothane and cyclopiazonic acid modulate Ca-ATPase oligomeric state and function in sarcoplasmic reticulum, Biochemistry 33, 13928-37.